Difference between revisions of "Phenytoin toxicity"

From WikEM
Jump to: navigation, search
(Management)
 
(One intermediate revision by one other user not shown)
Line 5: Line 5:
  
 
==Clinical Features==
 
==Clinical Features==
 
 
*CV (only with IV form)  
 
*CV (only with IV form)  
 
**Bradycardia  
 
**Bradycardia  
Line 20: Line 19:
 
**[[Nausea and vomiting]]
 
**[[Nausea and vomiting]]
 
*Skin
 
*Skin
**tissue infiltration (IV) → "purple glove syndrome"  
+
**tissue infiltration (IV) → "[[Purple glove syndrome]]"  
 
**edema, pain, ischemia, tissue necrosis, compartment syndrome
 
**edema, pain, ischemia, tissue necrosis, compartment syndrome
 
*Anticonvulsant hypersensitivity syndrome
 
*Anticonvulsant hypersensitivity syndrome
Line 27: Line 26:
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==
 +
  
 
==Evaluation==
 
==Evaluation==
Line 40: Line 40:
 
**POC glucose, rule out hypoglycemia as cause of AMS
 
**POC glucose, rule out hypoglycemia as cause of AMS
 
**[[Acetaminophen]] and [[salicylate toxicity|salicylate]] levels, rule out common coingestion
 
**[[Acetaminophen]] and [[salicylate toxicity|salicylate]] levels, rule out common coingestion
** Urine pregnancy test
+
**Urine pregnancy test
  
 
==Management==
 
==Management==
*Supportive care, A,B,C's
+
*Supportive care is mainstay of treatment
**If intubation needed, standard RSI meds ok, avoid lidocaine (same antidysrhythmic properties as phenytoin)
+
*If intubation needed, standard RSI meds ok, avoid lidocaine (same antidysrhythmic properties as phenytoin)
**If symptomatic bradydysrhythmia,
+
*If symptomatic bradydysrhythmia:
***[[ACLS: Bradycardia]], Atropine, epinephrine, dopamine are first line
+
**[[ACLS: Bradycardia]], Atropine, epinephrine, dopamine are first line
***May consider [[transcutaneous pacing|transcutaneous]] or [[transvenous pacing]]
+
**May consider [[transcutaneous pacing|transcutaneous]] or [[transvenous pacing]]
**Hypotension
+
*Hypotension
***IVF bolus
+
**IVF bolus
 
*Detoxification
 
*Detoxification
 
**[[Activated charcoal]] PO
 
**[[Activated charcoal]] PO
Line 62: Line 62:
  
 
==References==
 
==References==
 +
<references/>
  
 
[[Category:Toxicology]]
 
[[Category:Toxicology]]

Latest revision as of 01:18, 10 May 2017

Background

  • Mortality is extremely rare after intentional overdose if good supportive care is provided
  • Rapid IV dosing carries greatest risk (due to propylene glycol constituent of IV form → myocardia depression & cardiac arrest)
  • 90% protein bound; dialysis ineffective

Clinical Features

  • CV (only with IV form)
  • Neuro
    • Nystagmus
      • First only with forced lateral gaze; later becomes spontaneous
      • May disappear at higher levels
    • Ataxia
    • Decreased LOC
  • GI
  • Skin
    • tissue infiltration (IV) → "Purple glove syndrome"
    • edema, pain, ischemia, tissue necrosis, compartment syndrome
  • Anticonvulsant hypersensitivity syndrome

Differential Diagnosis

Evaluation

Toxicity symptoms by phenytoin level^

Level Sypmtoms
>10 Usually no symptoms
10-20 Occasional mild nystagmus
20-30 Nystagmus
30-40 Ataxia, slurred speech, Nausea/vomiting
40-50 Lethargy, confusion
>50 Coma, seizure (rare)

^Provides a rough guide only; neither sensitive nor specific

  • Correct for albumin level
    • Free phenytoin concentration determines toxicity
    • Hypoalbuminemia results in higher free phenytoin concentration
  • Other laboratory testing
    • LFTs, hepatic dysfunction increases risk of phenytoin toxicity
    • CBC, frequently show eosinophilia or marked leukocytosis
    • Total CK
    • ECG, may see arrhythmias, AV block, or sinus arrest with junctional or ventricular escape
    • POC glucose, rule out hypoglycemia as cause of AMS
    • Acetaminophen and salicylate levels, rule out common coingestion
    • Urine pregnancy test

Management

Disposition

  • Cannot base on phenytoin level (erratic absorption after PO overdose)
    • Consider discharge if patient has only mild symptoms and serial phenytoin levels decline

See Also

References